Post Covid19: Oncology Drugs Market To Reach USD 223 Billion By 2027 | CAGR 7.3% — Forencis Research

  • According to the new market research report Oncology Drugs Market by Form (Oral, Topical & IV), by Type (Targeted Therapy, Immunotherapy, Chemotherapy), by Cancer Type (Prostate Cancer, Brain Cancer, Ovarian Cancer, Breast Cancer, Bladder Cancer, Blood Cancer ), by Region (North America, Asia Pacific, Europe, Middle East and Africa, South America) — Global Forecast (2019 to 2027)”, the global ONCOLOGY DRUGS market is projected to reach a value of over USD 223 million, registering a CAGR of 7.3% during the review period
  • Oncology Drugs are the class of drugs used to treat, retard growth and kill the cancer cells
  • This includes chemotherapy, immunotherapy, pain killers, hormone therapy and others
  • The growing incidence of cancer with high mortality rate in the human population is creating higher need for oncology drugs
  • Rise in the cancer incidence globally with a high mortality rate is the prime driver driving the market growth
  • The demand for personalized medicine in on the constant rise, which is favoring the growth of the cancer drug market
  • High cost linked with new cancer drug development hampers the market growth
  • The market is expected to witness strong growth in the forecast owing to increased funding to cancer research with recent approvals on the new cancer drugs
  • Side-effects such as anemia, nausea, anorexia and others is acting as the challenge for the market growth
  • North America
  • Asia-Pacific
  • Hoffmann-La Roche Ltd:
  • Abbott Laboratories:

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
DataBridge Market Research

DataBridge Market Research

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approach